Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Difluprednate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 91,729Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adverum Presents Positive Ixo-vec Data At ASRS Meeting
    Adverum Presents Positive Ixo-vec Data At ASRS Meeting

    17 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/17/2914283/32452/en/Adverum-Biotechnologies-Presents-Positive-Ixo-vec-Clinical-Data-from-the-26-Week-Interim-Analysis-of-the-LUNA-Phase-2-Trial-at-the-2024-ASRS-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Jul 2024
    Share Share
    Epic Pharma's Generic Difluprednate Receives Approval in the U.S
    Epic Pharma's Generic Difluprednate Receives Approval in the U.S

    14 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207284

    FDA
    14 May 2024
    Share Share
    Dr. Reddy's announces the launch of Difluprednate Ophthalmic Emulsion 0.05%
    Dr. Reddy's announces the launch of Difluprednate Ophthalmic Emulsion 0.05%

    28 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230127005193/en

    BUSINESSWIRE
    28 Jan 2023
    Share Share
    Dr. Reddy's Generic Difluprednate Receives Approval in the U.S.
    Dr. Reddy's Generic Difluprednate Receives Approval in the U.S.

    16 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214894

    FDA
    16 Nov 2022
    Share Share
    Enforcement Report - Week of September 14, 2022
    Enforcement Report - Week of September 14, 2022

    14 Sep 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-14-2022-34762.pdf

    FDA
    14 Sep 2022
    Share Share
    Enforcement Report - Week of August 17, 2022
    Enforcement Report - Week of August 17, 2022

    17 Aug 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf

    FDA
    17 Aug 2022
    Share Share